Who We Are
News & Stories
Sep 22, 2023
Sep 21, 2023
September 27, 2023
September 28, 2023
University Wide Events
No Communication Compromises
Areas of Study
Changing the world
Community & Innovation
Research Experiences & Services
Our Global Presence
Global at Home
Global Learning For All
Your Journey Starts Here
Explore Our Campus
Jan 1, 1970
Sep 17, 2023
Aug 31, 2023
Faculty and Staff
Hearing, Speech, and Langua...
Deaf Cochlear Implant Users’ Perspectives on...
In the United States, candidacy and insurance coverage for cochlear implant (CI) technology is determined mainly by guidelines set forth by the Food and Drug Administration (FDA).
Current FDA guidelines for CI candidacy include meeting a minimum age requirement, having a certain degree of hearing loss, and demonstrating limited benefit from traditional hearing aid technology as determined by performance on speech perception tests.
Given the heavy reliance on speech perception measures in determining CI candidacy, research surrounding device outcome measures has also generally been based upon the acquisition and understanding of spoken language.
While speech perception assessments may be accurate tools to measure or determine device success for most CI users, this measurement pattern potentially omits a subset of the population – CI users with a preference for communicating via American Sign Language (ASL).
The purpose of this study is to shed light on the perspectives of CI users who identify ASL as their preferred or primary language. More specifically, this project aims to do the following:
Fill out our inquiry form for an Admissions Counselor to contact you.
Create an account to start Your Applications.
Already Started an Application? Log in to Submit your completed Application or Check your application status here.
Deaf Cochlear Implant Users’ Perspectives on Successful Device Outcome Measures
Gallaudet University, chartered in 1864, is a private university for deaf and hard of hearing students.
Copyright © 2023 Gallaudet University. All rights reserved.
800 Florida Avenue NE, Washington, D.C. 20002